Form 4: BioCardia CEO Peter Altman Increases Stake in Company

Peter Altman, the President and CEO of BioCardia, Inc., recently purchased additional shares of the company's common stock.

Summary

• On May 14, 2025, Peter Altman, President and CEO of BioCardia, Inc., purchased 100 shares of common stock at a price of $2.986 per share.
• On May 16, 2025, Altman purchased an additional 300 shares of common stock at a weighted average price of $2.432 per share, with individual trades ranging from $2.409 to $2.448.
• Following these transactions, Altman directly owns 139,366 shares of BioCardia's common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but the amount is relatively small.

Positives

• The CEO's purchase of additional shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive signal, suggesting that a company's management believes the stock is undervalued. However, it's important to consider the size of the purchases relative to the executive's overall holdings and the company's market capitalization.

Stakeholder Impact

• The CEO's increased stake could positively influence shareholder confidence.

Key Dates

Keywords

BioCardia, Peter Altman, BCDA, share purchase, common stock, insider trading, SEC Form 4